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INTRODUCTION
Helicobacter pylori (H. pylori) is a bacterium that
infects the mucus lining of the stomach and
duodenum. Many cases of peptic ulcers, gastritis and
duodenitis are caused by H. pylori infection.
However, many who are infected do not show any
symptoms of disease. Helicobacter bacteria are the
only known microorganisms that can thrive in the highly
acidic environment of the stomach. Its helical shape
(hence the name helicobacter) is thought to have
evolved to penetrate and colonize the mucus lining.1
Before the appreciation of the bacterium’s role,
stomach ulcers were typically treated with medicines
that neutralize stomach acid or decrease its
production. While this worked well, the ulcers very
often reappeared. A traditional medication against
gastritis was bismuth subsalicylate. It was very often
effective, but fell out of use, since its mechanism of
action was a mystery. Nowadays it is quite clear that it
is due to the bismuth salt acting as an antibiotic. Today,
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many stomach ulcers are treated with antibiotics
effective against H. pylori.1
The bacterium was initially named Campylobacter
pyloridis, then C. pylori (after a correction to the Latin
grammar) and in 1989, after DNA sequencing and
other data showed that the bacterium did not belong in
the Campylobacter genus, it was placed in its own
genus, Helicobacter. The name pylori comes from
the Greek word pylorus, which means gatekeeper, and
refers to the pyloric valve (the circular opening leading
from the stomach into the duodenum).1
While H. pylori remains the most important known
bacteria to inhabit the human stomach, several others
species of the Helicobacter  genus have now been
identified in other mammals and some birds, and some
of these can infect humans. Helicobacter species have
also been found to infect the livers of certain
mammals and to cause liver disease.1,2,3
In this literature review, it will be discussed about
the history, epidemiology, and structure of the
bacterium, clinical manifestations, transmission,
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HISTORY
In 1875, German scientists found spiral bacteria in
the lining of the human stomach; the bacteria could not
be grown in culture and the results were eventually
forgotten.1 In 1892, the Italian researcher Giulio
Bizzozero described spiral bacteria living in the acidic
environment of the stomach of dogs.1
Professor Walery Jaworski of the Jagiellonian
University in Krakow, Poland, investigated sediments
of gastric washings obtained from humans in 1899.
Among some rod-like bacteria, he also found bacteria
with a characteristic spiral shape, which he called
Vibrio rugula. He was the first to suggest a possible
role of this organism in the pathogenesis of gastric
diseases. This work was included in the “Handbook of
Gastric Diseases” but did not have much impact as it
was written in Polish.1
The bacterium was rediscovered in 1979 by
Australian pathologist Robin Warren, who did further
research on it with Barry Marshall beginning in 1981;
they isolated the organisms from mucosal specimens
from human stomachs and were the first to
successfully culture them. In their original paper,
Warren and Marshall contended that most stomach
ulcers and gastritis were caused by colonization with
this bacterium, not by stress or spicy food as had been
assumed before.1
The medical community was slow to recognize
the role of this bacterium in stomach ulcers and
gastritis, believing that no bacterium could survive for
long in the acidic environment of the stomach.
The community began to come around after further
studies were done, including one in which Marshall
drank a Petri dish of H. pylori, developed gastritis,
and the bacteria were recovered from his stomach
lining, thereby satisfying three out of the four Koch’s
postulates. Marshall’s gastritis later resolved without
treatment. Marshall and Warren went on to show that
antibiotics are effective in the treatment of gastritis.
In 1994, the National Institutes of Health (USA)
published an opinion stating that most recurrent gastric
ulcers were caused by H. pylori, and recommended
that antibiotics be included in the treatment regimen.
Evidence has been accumulating to suggest that
duodenal ulcers are also associated with H. pylori
infection.1
In June 1994, the International Agency for Research
on Cancer Working Group of the World Health
Organization identified H. pylori as a group I, or
definite, human carcinogen.3 In 2005, Warren and
Marshall were awarded the Nobel Prize in Medicine
for their work on H. pylori.1
EPIDEMIOLOGY
It is estimated that about 2/3 of the world
population are infected by the bacterium. Actual
infection rates vary from nation to nation - the West
(Western Europe, North America, Australia) having
rates around 25% and the Third World much higher.
In the latter, it is common, probably due to poor
sanitary conditions, to find infections in children.
In the United States, infection is primarily in the older
generations (about 50% for those over the age of 60
compared with 20% under 40 years) and the poorest.
This is largely attributed to higher hygiene standards
and widespread use of antibiotics.1
Structure of the Bacterium
Helicobacter pylori is a spiral-shaped Gram
negative bacterium, about 3 µm long with a diameter
of about 0.5 µm. It has 4 - 6 flagella. It is microaero-
philic, i.e. it requires oxygen but at lower levels than
those contained in the atmosphere. It contains
a hydrogenase and obtains energy by oxidizing
molecular hydrogen (H2) that was produced by other
intestinal bacteria. It tests positive for urease, oxidase
and catalase.1,2,3
Helicobacter pylori belongs to kingdom:
Bacteria, phylum: Proteobacteria, class: Epsilon
Proteobacteria, order: Campylobacter, family:
Helicobacteriaceae, Genus: Helicobacter and Species:
H. pylori.1 Under conditions of environmental stress,
Helicobacter will convert from the spiral to a coccoid
form. This coccoid form of the organism has not been
cultured, but has been found in the water supply in
the United States and is apparently involved in
the epidemiology of the bacterium. The coccoid form
has also been found to be able to adhere to gastric
epithelial cells in vitro.1
Clinical Manifestations
Persons infected with H. pylori may develop acute
gastritis (abdominal pain, nausea and vomiting) within
2 weeks following infections. H. pylori establishes
a chronic infection in the majority of infected
individuals, represented by chronic gastritis of
different types. Prominent mucosal inflammation in
chronic active gastritis is often evident in the antrum
(antral predominant gastritis) predisposing to
hyperacidity and duodenal ulcer disease. Many patients
infected with H. pylori have recurrent abdominal
symptoms (nonulcer dyspepsia) without ulcer disease.
Inflammation of the duodenum (duodenitis) often
occurs in patients with H. pylori infection, and
duodenal ulcers develop in as many as 16% of infected
individuals. H. pylori infection has been associated with
the majority of duodenal and gastric ulcers. In patients
with long-standing H. pylori infection, persistent
inflammation can lead to multifocal atrophic gastritis.
Multifocal atrophic gastritis is a recognized precursor
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state for gastric ulcer disease and gastric adeno-
carcinoma.3 Helicobacter pylori infection is now
accepted as the most common cause of gastritis, and
is etiologically involved in dyspepsia, gastric ulcer,
duodenal ulcer, gastric adenocarcinoma and primary
gastric B - cell lymphoma.1,2
TRANSMISSION
Transmissions of H. pylori are by fecal-oral and
oral-oral. Oral-oral transmission is supported by
the frequent presence of H. pylori in the oral cavities
of infected individuals.3
PATHOGENESIS
Pathogenesis of H. pylori infection is strongly
associated with its ability to produce catalase, urease,
ability to adhere to gastric cells which produce mucus,
ability to inhibit gastric acid secretions, cag A antigen
and vacuolating toxin.4
Ability to produce catalase protects H. pylori from
the neutrophils immunological defense. Normally,
neutrophils synthesize bactericidal oxygen metabolites
from peroxide in order to fight foreign bacteria.
Catalase interferes with this synthesis by splitting
the peroxide molecule into non-harmful products
(H2O and CO2).4
Helicobacter pylori produce urease, an enzyme
that splits urea in the stomach into NH3 and H2O
leading to an accumulation of ammonium ions. It is
presumed this imbalance in the environment’s ionic
integrity results in a back - diffusion of hydrogen ions
(H+), and consequently to tissue injury. Helicobacter
pylori’s urease varies in structure and potential from
other ureases produced by other organisms found in
the gut. Its low Michelis constant (Km = 0.2-0.3)
allows it to be fully functional in such low urea
concentrations present in the stomach.4
Helicobacter pylori’s ability to attach to gastric
mucus-secreting cells can cause structural alterations
of cytoskeletal elements as well as effacement of
microvilli. It is presumed antibodies to H. pylori may
prevent the organism from adhering.4 Ability to inhibit
gastric acid secretions is responsible for the transient
hypochlorhydria observed in individuals recently
infected with H. pylori.4
CagA antigen (cytotoxin associated) is a high
molecular weight protein (120-140 kilo Daltons)
expressed approximately in 60-70% of H. pylori
strains. CagA antigen is thought to be strongly
associated with the presence of a vacuolating toxin
responsible for eliciting degrees of inflammation
significantly higher than CagA (-) strains. Chronic
gastritis patients infected with CagA (+) strains are
thought to be more prone to develop duodenal ulcers.4
Vacuolating toxin is produced by H. pylori and it
can damage gastric epithelial cells by induce
vacuolisations. Type s1a of this toxin is associated with
enhanced gastric inflammation and duodenal ulcer while
those with type s2 were associated with less damage.5
DIAGNOSTIC TESTS FOR HELICOBACTER PYLORI
INFECTION
Diagnostic tests for H. pylori infection can be
divided into 2 categories, invasive and non invasive
methods.5
Invasive Methods
Invasive methods to diagnose H. pylori infection
are performed by endoscopy and biopsy. Gastric
biopsies are tested with culture, histologic assessment,
urease test and PCR test.3,5
• Culture
Culture of H. pylori has 2 major advantages. First,
it allows antimicrobial susceptibility testing and
second, isolates obtained by culture can be further
studied for its characteristics.5 Gastric biopsies
should be cultured immediately. If it is delayed less
than 6 hours, sterile saline can be used as transport
medium although other researchers did not agree.
But if the culture is to be delayed more than 6 hours,
more complex media such as Stuart’s transport
medium or supplemented brain heart infusion broth
should be used. Media containing glycerol are
suitable for long-term storage of biopsy specimens
at -70o C, or the specimens can be immediately
frozen at - 70oC without a fluid medium.4,5
A variety of selective and non - selective medium
are available commercially for culture of
H. pylori. The use of multiple media may increase
sensitivity.5
Consistent isolation of H. pylori from gastric
biopsy specimen requires processing by
homogenization or vortexing prior to plating.3 It is
recommended that gastric biopsy specimens are
ground at 10,000 rpm for 15 seconds with an
electric tissue homogenizer and then inoculated onto
selective Columbia blood agar and incubated
under microaerophilic (5% O2, 10% CO2 and 85%
N2) environment, high humidity, and conditions at
35 to 37o C for a maximum of 7 to 10 days.
Positive cultures are usually detected after 3 to
5 days of incubation. H. pylori is identified on the
basis of colony morphology (translucent colonies
varying in size from barely detectable with
the naked eye to approximately 3 mm); colonies
consist of Gram-negative, curved (not usually
helical) rods that are rapid - urease, catalase, and
oxidase  positive. The addition of tetrazolium salts
aids in the identification of H. pylori colonies
cultured on agar media.5,6
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H. pylori belongs to fastidious micro organisms.
And it is often more difficult to isolate it because
its ability to grow is reduced when patients have
taken simethicone, prior antibiotics, H2 receptor
antagonists or proton pump inhibitors. Since
H. pylori is sensitive to oxygen, the efficacy of
H. pylori culture also depends on the time lag
between the time of sampling by endoscopy &
biopsy and the start of culture of the sample under
microaerophilic conditions.7
Culture of H. pylori is difficult to perform and there
might be human error in its culture interpretation.
Van Doorn LJ, found the sensitivity of culture is
89.5%.7 Monteiro et al, in their research found that
the sensitivity, specificity, positive predictive value
(PPV) and negative predictive value (NPV) of
culture method is 93.8%, 100%, 100% and 94.9%
respectively. Helicobacter pylori positive culture
confirms the presence of H. pylori infections but
negative culture does not exclude its presence.8
• Histologic assessment
H. pylori can be visualized at high magnification
with conventional hematoxyllin and eosin (H & E)
stained sections. Bacteria are located in the
mucus adherent to the surface epithelium and are
often found deep within the crypts. However, H&E
staining may be unreliable when few bacteria are
present. In addition, luminal debris on the surface
of the epithelium can be mistaken for H. pylori in
H & E stained sections. Histologic identification of
bacteria, is facilitated by using special stains such
as the Warthin - Starry and modified Giemsa
stains.5,9
Histologic identification of bacteria with
the characteristic morphology of H. pylori is, in
part, observer dependent. Factors that influence
the ability to correctly identify H. pylori include
bacterial density, type of stain used, and
the enthusiasm and experience of the laboratorian.5
The limitations of histologic assessment are
the distribution of H. pylori in the stomach is patchy,
nor are organisms usually found in areas of
intestinal metaplasia. This condition some time
makes discrepancy result when the tissue biopsy
taken by endoscopy does not contain any
H. pylori.5,9
Monteiro et al,8 found the sensitivity, specificity,
PPV and NPV of histologic examinations by
Giemsa stain is 93.8%, 98.2%, 97.9% and 94.8%
respectively. Cutler et al,9 found that Warthin -
Starry staining had the best sensitivity and
specificity i.e. 93.1% and 99% respectively when
compared with CLO test, 13C urea breath test and
serum IgG levels in determining H. pylori
infection. The PPV and NPV of Warthin - Starry
staining are 99.4% and 88.7% respectively.
• Biopsy urease test
The early observation that H. pylori produces large
amounts of urease activity led to the development
of methods for the indirect detection of
the organism in gastric biopsy tissue.
The sensitivity of all urease - based tests for
detection of H. pylori is dependent upon
the bacterial load in the stomach.5
The CLO test (stands for Campylobacter Like
Organism Test, Delta West Ltd., Bentley,
Australia) developed by Marshall, was the first of
the commercially available biopsy urease tests
designed specifically for H. pylori detection.
The principle of this test is qualitative test of rapid
urease enzymes which is produced by H. pylori in
the tissue biopsy. In this test, gastric tissue is put
into gel media contained urea and phenol red
(pH indicator). After incubation, urease enzyme of
H. pylori will split the urea into ammonia (NH3)
and CO2. Ammonia will react with water to form
NH4OH and change the pH of the medium into
alkaline which then change the color of pH
indicator from yellow to magenta. The test is
interpreted up to 24 hours after placement of
the gastric biopsy sample onto the agar gel.4,5
Two other biopsy urease tests are available
commercially: Hpfast, a gel test similar to CLO
test but with a different pH indicator at lower pH,
and PyloriTek, a strip test. In the latter test, in the
presence of urease, ammonia is produced from urea
impregnated into a pad. The diffusion of ammonia
through a membrane is detected by an overlying
pH indicator. A potential advantage is that
interpretation requires no more than one hour.
Comparative studies of the sensitivity and
specificity of the CLO test, Hpfast and Pylori Tek
test have been performed. The overall sensitivities
were equivalent (88 to 93%) and the specificities
were excellent (99 to 100%). At one hour (the end
point for reading PyloriTek), the sensitivities of the
gel tests were significantly lower (66 to 71%).
The Pylori Tek test seems to be the test of choice,
if a rapid result (one hour or less) is desired. How-
ever, if rapid results are not needed, all three tests
provide equivalent accuracies and the choice may
be made based on cost, regulatory issues,
availability; physician preference, or other factors.
An important point to keep in mind is that increased
incubation time may lead to improved sensitivity of
biopsy urease tests but to decreased specificity of
detection of H. pylori.5
Sources of error in this test might come from:
(1) when the biopsy tissue was contaminated with
blood or bile secretions, which create alkaline
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conditions can give false positive results;
(2) if  the CLO card/gel does not reach 30oC-40oC
when the test was performed, can give false
negative results  because the reaction will take place
very slow; (3) recent ingestion of  antibiotics or
bismuth salts, which kill the bacteria and will give
false negative results; (4) formalin contamination
of the specimen will give false negative results; (5)
in patients with achlorhydria, the results will be false
positive such as in pernicious anemic patients,
gastrectomy patients, and in patients taking antac-
ids or large doses of H2 receptor antagonist.4
Monteiro et al, found that the sensitivity, specificity,
PPV and NPV  of CLO test are 83.0%, 96.4%,
95.1% and 87.1% respectively.8 Cutler et al, found
that the sensitivity, specificity, PPV and NPV of
CLO  test are 89.6%, 100%, 100% and 84.1%
respectively.9
• Tissue biopsy PCR (Polymerase Chain
Reaction) test
PCR technique is a technique which is expected to
give results with high sensitivity and specificity in
detecting H. pylori infections. But there are many
factors which influence the accuracy of this test.
These factors are primers and target DNA,
specimen preparations, bacterial density, genotypes
and the PCR technique applied.5,7
On tissue biopsy, PCR technique can be applied to
detect H. pylori by detecting DNA targets such
as ureC or 16 S rRNA. It can be also applied to
determine bacterium’s genotype by detecting
specific genes such as vacA, cagA and iceA6,7 and
can also detect mutations which induce
the bacterium’s resistance against clarythromycin
by detecting DNA target 23 S rRNA.10
Sensitivity and specificity of PCR technique
applied in tissue biopsy varied in several studies.
Lage et al, found the sensitivity, specificity, PPV
and NPV of PCR with ureC as target DNA are
100%, 97%, 95% and 100% respectively.6 Van
Doorn LJ et al, found  the sensitivity of  PCR with
vacA and cagA gene as target DNA is the highest
(99.4%) compared with histology (92.2%), culture
(89.5%) and CLO test (89.0%).7 Monteiro et al,
found the sensitivity, spedificity, PPV and NPV of
ureC/glmM gene PCR are 91.5%, 96.4%, 95.6%
and 92.9% respectively.8 Chisholm et al, found the
sensitivity of PCR with 16 S rRNA as target gene
is 82.3%.10
Non Invasive Methods
Non-invasive methods to diagnose H. pylori
infections consist of urea breath test (UBT), 15NH4+
excretion test, antibody detection, fecal antigen
detection of H. pylori and fecal PCR detection of
H. pylori.
• Urea Breath Test (UBT)
The test is based on strong urease activity
produced by H. pylori. A solution containing
 isotopically labeled urea (14C or 13C) is consumed
by the patient. The isotopically labeled urea will be
split by H. pylori urease into ammonia (NH3) and
isotopically labeled carbon dioxide (14CO2 or
13CO2). Isotopically labeled carbon dioxide will be
absorbed from the stomach into bloodstream and
then released in the lung, exhaled by the patient
and collected 30 minutes after ingestion of labeled
urea in a bottle containing ‘trapping solution’.
The 14CO2 in the trapping solution will be measured
by scintillation particle counter and the 13CO2
will be measured by gas isotope ratio mass
spectrometry.5,8 The principle of urea breath test
is showed in figure 1.
Figure 1. The principle of urea breath test.11
Some micro organisms within the oropharynx also
may hydrolyze urea; therefore, if the urea is
presented in liquid form, an early peak in labeled
CO2 may occur during the breath test. Thus,
the timing of breath collection, the form of delivery
of urea (liquid versus tablet form), the gastric
emptying time and other factors may influence
the accuracy of the test.5
The following precautions are necessary to get
a good result: (1) Do not eat or drink 4 hours prior
to the test; (2) Stop all antibiotics, proton pump
inhibitors and H2 receptor antagonists 4 weeks prior
to the test. If it is difficult to stop all the
medications for 4 weeks, it could be reduced to
one week.5
Monteiro et al, found the sensitivity, specificity, PPV
and NPV of UBT are 93.8%, 100%, 100% and
94.9% respectively.8 Cutler et al, found
the sensitivity, specificity, PPV and NPV of UBT
are 90.2%, 95.8%, 97.5% and 84.3% respectively.9
•
15NH4+ excretion test
This test is also based on the strong urease activity
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produced by H. pylori. After oral ingestion of 15N
labeled urea tablet, 15N urea will be split into
labeled ammonia (15NH3) and CO2 by H. pylori
urease in the stomach. Labeled ammonia (15NH3)
will react with H2O to become 15NH4OH and then
split again into 15NH4+ and OH-. The 15NH4+ will
be absorbed into the blood stream, reach
the kidney and then excreted in urine. The amount
of 5NH4+ excreted in urine will be measured by
mass spectrometry and reflect the magnitude of
H. pylori infection. Cut off value is determined by
measuring the excretion rate in normal healthy
people.12
Several precautions are necessary when the 15NH4+
excretion test is performed. First, an overnight fast
prior to the test is required because meal
consumption dilutes the concentration of urease in
the stomach, particularly if the infection is weak,
and thus can produce a false - negative result.
Second, it is necessary to rinse the mouth before
the test to avoid contamination by normal flora in
the mouth. Third, it is important to collect urine for
2 hours, because the excretion of 15N in urine
ammonia peaks within 1 to 2 hours after the tracer
is ingested. Several drops of HCl should be added
to prevent evaporation of urine ammonia. The urine
can be stored at -30oC for 2 weeks without any
obvious change in 15N amount in urine ammonia.12
False positive results can be obtained if
Gastrospirillum hominis is present, but this is
seldom encountered.
• Serologic test of IgG and IgA in the blood
Infection of the gastric mucosa with H. pylori
results in systemic as well as local immune
response, including elevation of specific IgG and
IgA levels in serum and elevated levels of
secretory IgA and IgM in the stomach, thus
allowing the development of serologic tests for
detection of the bacteria. Serologic methods have
proven especially valuable in screening large
numbers of individuals in epidemiologic studies
because these tests are non - invasive, relatively
rapid and simple to perform, and much less
expensive than tests requiring endoscopic biopsy.
Another advantage of serologic test is less
influenced by suppression of H. pylori infection
by bismuth compounds, proton pump inhibitors, or
antibiotics taken for unrelated conditions than are
urease - based tests, which are dependent upon
and reflect the current bacterial load. Although a
wide variety of serologic methods for detection of
H. pylori have been described in the literature, most
tests available commercially are enzyme-linked
immunosorbent assay (Elisa) methods.5
Serologic tests for the detection of H. pylori
specific antibodies is dependent on the antigen used.
In general, there are 3 types of antigen have been
used, these are (1) crude antigens such as whole
cells and whole - cell sonicates, (2) cell fractions
such as glycine extracts and heat-stable antigens,
and (3) enriched antigens such as urease and
a 120 - kDa antigen.5
Serologic tests to diagnose H. pylori infection in
children is still controversial because it is reported
to have lower sensitivity results in children
compared to adults.13 Kindermann et al, evaluated
2 commercial enzyme immunoassays testing IgG
and IgA antibody for diagnosis of H. pylori
 infection in children. A child was considered
H. pylori infected if at least two of three tests
(histology, rapid urease test, 13C-urea breath test)
or culture were positive and non infected if all
results were concordantly negative.13 They found
the sensitivity varied markedly between tests and
was 92.7%, 70.7%, 47.5% and 24.4% for
Enzygnost II IgG, Pyloriset IgG, Enzygnost II IgA
and Pyloriset IgA  respectively. Sensitivity was very
low for the two IgA-based tests independent of
age group, sex and nationality. They also found that
measurement of specific IgA in addition to IgG
antibodies hardly improved the sensitivity.
The specificity was excellent for all four EIAs
(95.7% to 97.9%).13
Commercially available serologic tests to detect IgG
and IgA, are Elisa method (IgG and IgA) and
immunoblot (IgG).8 Monteiro et al, found
the sensitivity, specificity, PPV and NPV of
serum IgG detection by Elisa and  immunoblot are
93.8%, 94.6%, 93.9%, 96.4 % and 95.8%, 94.6%,
93.9%, 96.4% respectively. 8 Cutler et al,
in the study of 268 patients found the sensitivity,
specificity, PPV and NPV of serum IgG (Elisa)
are 91.3%, 91.6%, 95.2% and 85.3% respectively
and IgA (Elisa) are 71.1%, 85.3%, 89.8% and
61.8% respectively.9
In the absence of therapeutic intervention, antibody
levels remain elevated, perhaps for a life-time,
reflecting the duration of infection. After
eradication of H. pylori, specific IgG and IgA
 levels tend to decrease, typically to approximately
half of the pretreatment value within six months.
Low levels of specific IgG tend to persist for months
even after eradication of H. pylori; therefore,
using serologic tests to assess the effects of
treatment may be problematic unless the pre and
post treatment sera can be directly compared.5
In certain conditions, IgG serologic test is better
compared to other tests. Such as in gastric
atrophy, IgG serologic test may give positive result
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while biopsy or urea breath test will be negative
because the number of H. pylori is so small to be
detected.
A negative serologic test predicts a low probability
of infection in a patient with a low likelihood of
infection, and further evaluation for infection is
unnecessary.5
• Detection of H. pylori antigen in stool
One of the available methods for fecal H. pylori
antigen detection is sandwich solid phase
immunochromatographic assay. To perform the test,
an aliquot of diluted stool sample is added to a label
pad containing H. pylori antibody coupled to
red-colored colloidal gold. If the sample contains
H. pylori antigens, the antigen will bind to
the antibody coated on the colloidal gold particles
to form antigen-antibody-gold complexes. These
complexes move on the nitrocellulose membrane
by capillary action toward the test line region on
which H. pylori specific antibodies are
immobilized. As the complexes reach the test line,
they will bind to the antibody on the membrane in
the form of a line. A second red control line will
always appear in the result window to indicate that
the test has been correctly performed and the test
device functions properly. If the control line does
not developed, the test is invalid.14
If the test gives negative result, it means that
H. pylori antigen is not present or lower than
the detection limit of the test.12 One example is
RapidTech Plus H. pylori antigen test which has
sensitivity, specificity, PPV and NPV of  94.0%,
96.7%, 92.2% and 97.5% respectively.14
Sources of error in this test may come from (1)
stool specimen is watery or diarrhea, (2) the result
is read more than the allowed time,  for instance
more than 15 minutes and  (3)  reagents is used
before they reach room temperature
(200C-30o C).14
Recently, a novel enzyme immuno assay (EIA;
Premier Platinum HpSA; Meridian Diagnostics Inc,
Cincinnati, Ohio) utilizing immunoaffinity-purified
polyclonal anti- H. pylori rabbit antibody adsorbed
to microwells for detection of H. pylori antigen
has been developed. This test is a microwell - based
EIA that detects H. pylori antigens present in
human stools. Polyclonal anti-H. pylori antibodies
coated on microwells were used to capture
H. pylori antigens. Diluted stool samples,
a peroxidase conjugated polyclonal antibody and
a substrate of the enzyme were subsequently used.
A positive result was defined as an absorbance
>160, a negative results as an absorbance < 140,
and an undetermined result when absorbance was
> 140 but < 160.8
Monteiro et al, found the sensitivity, specificity, PPV
and NPV of HpSA test as 89.6%, 92.9%, 93.5%
and 91.2% respectively.8 Makristathis A et al, found
the sensitivity, specificity, PPV and NPV of HpSA
test as 88.9%, 94.6%, 96.6% and 83.3%.15
• Detection of H. pylori in stool by PCR
A highly sensitive seminested PCR assay to detect
H. pylori DNA in stool was developed by
Makristathis et al, This PCR test was based on
the DNA sequence of a species-specific protein
antigen with a molecular weight of 27,000 Dalton.
They found the sensitivity, specificity, PPV and
NPV of the test as 93.7%, 100%, 100% and 90.2%
respectively.15
The stool PCR method described by Makristathis
et al, appears to be highly sensitive and specific.
This could be achieved by the semi-nested PCR
and also by the removal of potential inhibitory
substances present in feces. Elimination of these
substances was done by centrifugation steps,
column chromatography, phenol-chloroform
extraction, and a concentration step with
a Microcon 100 filter. The final step is to remove
remaining nonbiological inhibitory substances as well
as complex polysaccharides (molecular weight, as
much as 80,000 Dalton), which have been found to
be potent PCR inhibitors, and allows elimination of
time-consuming DNA precipitation.15
CONCLUSION
Diagnostic tests for H. pylori infection can be
divided into 2 categories, invasive and non-invasive.
Invasive methods are done by endoscopy and biopsy.
Gastric biopsy is then tested with culture, histologic
assessment, urease (CLO test) and PCR (Polymerase
Chain Reaction). Non-invasive methods consist of urea
breath test, 15NH4+ excretion test, serologic test of IgG
and IgA in the blood, detection of H. pylori antigen in
stool and detection of H. pylori in stool by PCR.
All these tests have its own advantages and
limitations. But non-invasive tests have several
advantages compared to invasive tests as cheaper,
more convenient and easier to perform. To apply these
tests accurately, it is very important to understand
the principle of the test, how to perform the test,
the sensitivity, specificity, positive predictive value,
negative predictive value and to recognize all
the sources of error which can happen with each test
and accurate interpretation.
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